Medical Research News

RSS

Neuroscience research in South Australia is mobilising its efforts against diseases of the brain and nervous system

Neuroscience research in South Australia is mobilising its efforts against diseases of the brain and nervous system that cause Australians incalculable distress as well as costing billions of dollars each year in treatment and care.

9 Aug 2004

Carb-conscious dieters may be lowering their risk of breast cancer

Carb-conscious dieters may be lowering their risk of breast cancer while they’re shedding pounds, based on the findings of research published in this month’s edition of the journal Cancer Epidemiology, Biomarkers & Prevention.

9 Aug 2004

Scientists lead fight against blood cancers

The Leukaemia Research Fund has awarded £140,000 to three teams working within the Nuffield Department of Clinical Laboratory Sciences to find and improve treatments for leukaemia and related blood cancers.

7 Aug 2004

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

The lack of a gene called LBP-1a in the mouse embryo prevents normal growth of blood vessels in the placenta. This finding suggests that a similar defect in humans could play a role in fetal growth retardation, infant mortality and spontaneous abortion.

6 Aug 2004

World's young and leading scholars will gather in Sydney next week to showcase their research

Doctoral students from 36 of the world's leading universities will meet at the University of Sydney for a conference designed to foster cooperation in education and research.

6 Aug 2004

Short bouts of exercise reduce the risk of heart disease

Accumulated, short bouts of exercise are more effective than continuous exercise for lowering fat and triglyceride levels in the bloodstream after eating.

6 Aug 2004

Personalised medicine designed to enhance people's chances of quitting smoking

The latest spin-out from the University of Oxford, G-Nostics, focuses on personalised medicine designed to enhance people's chances of quitting smoking.

6 Aug 2004

Australian university signs multi-million dollar anti-cancer research deal

Australia's University of Newcastle Research Associates (TUNRA) Ltd has signed a licensing agreement worth approximately $10 million with the biotechnology company Psiron Ltd to develop anti-cancer treatments.

5 Aug 2004

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research with an aggressive set of technology initiatives. The goal is to take advantage of an explosion in new medical data to drive tighter linkage between research and the practice of medicine to achieve breakthroughs.

5 Aug 2004

First evidence of the molecular link between inflammation and cancer

The investigators found that a gene called I-kappa-B kinase (IKK beta), a pro-inflammatory gene, acts differently in two cell types to cause cancer. When IKK beta was deleted, the cancer incidence and tumor growth in mice was decreased by nearly 80 percent.

5 Aug 2004

New gene-silencing technique

A new gene-silencing technique that takes place in the nucleus of human cells, has been demonstrated by researchers at the University of California, San Diego (UCSD) School of Medicine and the VA San Diego Healthcare System.

5 Aug 2004

Potential of genomics in disease research yet to be realized

Over the past decade genomics has revolutionized our understanding of how microorganisms cause disease. However, genomic studies need to be extended to a more diverse array of microorganisms and research tools improved to gain additional insights into pathogenesis, according to a new report released by the American Academy of Microbiology.

5 Aug 2004

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

Brown University researchers have discovered that mefloquine, an anti-malarial drug, blocks two gap junction proteins, or connexins, in low doses and with very few side effects in the brains of laboratory mice.

5 Aug 2004

As medicine targets personal DNA profiles, researchers examine ethics and patient experiences

Researchers at the University of York are beginning a major study into the ethical and personal issues raised by a potential revolution in healthcare, which could incorporate individualised medical care – pharmacogenetics - into clinical practice.

5 Aug 2004

Nogo protein may control the progression of Alzheimer’s disease

Researchers in the Department of Neurosciences at The Cleveland Clinic Lerner Research Institute have found that Nogo, a protein known for its ability to regulate nerve regeneration, may control the progression of Alzheimer’s disease.

3 Aug 2004

Researchers study whether people’s genetic makeup could make them more likely to develop osteoarthritis of the knee and hip

Researchers at The University of Nottingham are studying whether people’s genetic makeup could make them more likely to develop osteoarthritis of the knee and hip — the most common medical condition to affect the joints.

3 Aug 2004

Smart drug that targets cancer cells in the brain following removal of a tumor

The use of a "smart" drug that targets cancer cells in the brain following removal of a tumor may provide treatment that can extend the survival of people with the most common form of primary malignant brain tumor, glioblastoma multiforme (GBM).

3 Aug 2004

Entirely new approach to the treatment of aging

Dispelling the belief that the only way to treat such conditions is by fixing or replacing damaged genes, they instead focused on the field of epigenetics—the study of changes in gene silencing that occur without changes in the genes themselves.

3 Aug 2004

Switches in the brain that tell the body to stop eating and start burning calories

A Brown-led research team has discovered a pair of universal switches in the brain that tell the body to stop eating and start burning calories.

3 Aug 2004

Adolescents hospitalized for psychiatric disorders are more likely to report higher levels of emotional distress as adults

The Archives of Pediatrics & Adolescent Medicine reports that adolescents hospitalized for psychiatric disorders are more likely to report higher levels of emotional distress as adults, and are less likely to graduate from high school and complete college or graduate school.

2 Aug 2004

Medical Research News

Neuroscience research in South Australia is mobilising its efforts against diseases of the brain and nervous system

Carb-conscious dieters may be lowering their risk of breast cancer

Scientists lead fight against blood cancers

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

World's young and leading scholars will gather in Sydney next week to showcase their research

Short bouts of exercise reduce the risk of heart disease

Personalised medicine designed to enhance people's chances of quitting smoking

Australian university signs multi-million dollar anti-cancer research deal

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research

First evidence of the molecular link between inflammation and cancer

New gene-silencing technique

Potential of genomics in disease research yet to be realized

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

As medicine targets personal DNA profiles, researchers examine ethics and patient experiences

Nogo protein may control the progression of Alzheimer’s disease

Researchers study whether people’s genetic makeup could make them more likely to develop osteoarthritis of the knee and hip

Smart drug that targets cancer cells in the brain following removal of a tumor

Entirely new approach to the treatment of aging

Switches in the brain that tell the body to stop eating and start burning calories

Adolescents hospitalized for psychiatric disorders are more likely to report higher levels of emotional distress as adults

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News